Adverse effects of sustained-release niacin.
Knapp
T R
TR
Drug Information Analysis Service, University of California, San Francisco 94143.
Middleton
R K
RK
D003692:Delayed-Action Preparations; D005483:Flushing / Q000139:chemically induced / Q000188:drug therapy*; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D009525:Niacin / Q000008:administration & dosage / Q000009:adverse effects*
D003692:Delayed-Action Preparations; D009525:Niacin